| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 11, 1021-1031, Copyright © 1997 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
S De Flora, A Izzotti, D Walsh, P Degan, GL Petrilli and J Lewtas
Institute of Hygiene and Preventive Medicine, University of Genoa, Italy.
It has been hypothesized that mutational events may be involved in the atherogenetic process and that at least a portion of atherosclerotic plaques may develop according to an initiation-promotion process of arterial smooth muscle cells, akin to benign tumors. We conducted a study to evaluate the occurrence of oxidative DNA damage and formation of DNA adducts in human atherosclerotic lesions and to assess the relationships of these promutagenic alterations with exposure to atherogenic risk factors. Pure DNA was extracted from the tunica media (composed mainly of smooth muscle cells) of abdominal aorta fragments taken at surgery from 85 patients suffering from severe atherosclerotic lesions. DNA adducts were detected by synchronous fluorescence spectrophotometry and 32P postlabeling after enrichment of adducts with either butanol or nuclease P1. 8-Hydroxy-2'-deoxyguanosine (8-OH-dG), a typical indicator of oxidative DNA damage, was measured by HPLC/electrochemical detection. A complete questionnaire reporting general, clinical, and laboratory characteristics was available for each patient. All 84 samples tested by 32P postlabeling were positive by displaying the presence of diagonal radioactive zones and up to 9 individual DNA adducts. Of 52 samples tested, 32 (61.5%) yielded typical positive signals at synchronous fluorescence spectrophotometry. All but one of 39 samples tested had very high levels of 8-OH-dG, thus showing a remarkable oxidative DNA damage. Statistically significant correlations were found between the levels of molecular biomarkers and atherogenic risk factors including age, number of currently smoked cigarettes, ratio of total-to-high density lipoprotein blood cholesterol, blood triglycerides, and blood pressure. The DNA alterations detected in our study may be only one component of the genetic basis of atherogenesis. Moreover, no causal role in the atherogenetic process can be inferred from our results. However, DNA alterations, including oxidative damage and adduction of reactive molecules of either endogenous or exogenous source, were systematically present in the smooth muscle cells of human atherosclerotic lesions and their intensity was significantly correlated with the occurrence of atherogenic risk factors in the patients studied.
This article has been cited by other articles:
|
|
 |
|
  J. K. Folkmann, S. Loft, and P. Moller Oxidatively damaged DNA in aging dyslipidemic ApoE-/- and wild-type mice Mutagenesis, March 1, 2007; 22(2): 105 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zhang, J. Yang, and L. K. Jennings Attenuation of neointima formation through the inhibition of DNA repair enzyme PARP-1 in balloon-injured rat carotid artery Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H659 - H666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Mulvihill, J. Jaeger, R. Sengupta, W. L. Ruzzo, C. Reimer, S. Lukito, and S. M. Schwartz Atherosclerotic Plaque Smooth Muscle Cells Have a Distinct Phenotype Arterioscler. Thromb. Vasc. Biol., July 1, 2004; 24(7): 1283 - 1289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Ramakrishna, T. W Rooke, and L. T Cooper Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light Vascular Medicine, August 1, 2003; 8(3): 203 - 210. [Abstract] [PDF]
|
|
|
|
|
|
W. Greenrod and M. Fenech The principal phenolic and alcoholic components of wine protect human lymphocytes against hydrogen peroxide- and ionizing radiation-induced DNA damage in vitro Mutagenesis, March 1, 2003; 18(2): 119 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Andreassi, N. Botto, A. Rizza, M. G. Colombo, C. Palmieri, S. Berti, S. Manfredi, S. Masetti, A. Clerico, and A. Biagini Deoxyribonucleic acid damage in human lymphocytes after percutaneous transluminal coronary angioplasty J. Am. Coll. Cardiol., September 4, 2002; 40(5): 862 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Martinet, M. W.M. Knaapen, G. R.Y. De Meyer, A. G. Herman, and M. M. Kockx Elevated Levels of Oxidative DNA Damage and DNA Repair Enzymes in Human Atherosclerotic Plaques Circulation, August 20, 2002; 106(8): 927 - 932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Jenner, J. E. Ruiz, C. Dunster, B. Halliwell, G. E. Mann, and R. C.M. Siow Vitamin C Protects Against Hypochlorous Acid-Induced Glutathione Depletion and DNA Base and Protein Damage in Human Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., April 5, 2002; 22(4): 574 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Jenner, J. E. Ruiz, C. Dunster, B. Halliwell, G. E. Mann, and R. C.M. Siow Vitamin C Protects Against Hypochlorous Acid-Induced Glutathione Depletion and DNA Base and Protein Damage in Human Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., April 5, 2002; 22(4): 574 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. De Flora, A. Izzotti, F. D'Agostini, and R. M. Balansky Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points Carcinogenesis, July 1, 2001; 22(7): 999 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. IZZOTTI, C. CARTIGLIA, J. LEWTAS, and S. DE FLORA Increased DNA alterations in atherosclerotic lesions of individuals lacking the GSTM1 genotype FASEB J, March 1, 2001; 15(3): 752 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Izzotti, R. M. Balansky, F. D’Agostini, C. Bennicelli, S. R. Myers, C. J. Grubbs, R. A. Lubet, G. J. Kelloff, and S. De Flora Modulation of Biomarkers by Chemopreventive Agents in Smoke-exposed Rats Cancer Res., March 1, 2001; 61(6): 2472 - 2479. [Abstract] [Full Text]
|
|
|
|
|
|
M. H. WILSON, P. J. GRANT, L. J. HARDIE, and C. P. WILD Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction FASEB J, April 1, 2000; 14(5): 791 - 796. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Dreyer and J. H. Olsen Risk for Non-smoking-related Cancer in Atherosclerotic Patients Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 915 - 918. [Abstract] [Full Text]
|
|
|
|
|
|
A. Izzotti, M. Bagnasco, F. D'Agostini, C. Cartiglia, R. A. Lubet, G. J Kelloff, and S. De Flora Formation and persistence of nucleotide alterations in rats exposed whole-body to environmental cigarette smoke Carcinogenesis, August 1, 1999; 20(8): 1499 - 1506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. De Flora, M. Bagnasco, and H. Vainio Modulation of genotoxic and related effects by carotenoids and vitamin A in experimental models: mechanistic issues Mutagenesis, March 1, 1999; 14(2): 153 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bogliolo, A. Izzotti, S. De Flora, C. Carli, A. Abbondandolo, and P. Degan Detection of the `4977 bp' mitochondrial DNA deletion in human atherosclerotic lesions Mutagenesis, January 1, 1999; 14(1): 77 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Van schooten, A. Hirvonen, L. M. Maas, B. A. De mol, J. C. S. kleinjans, D. A. Bell, and J. D. Durrer Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue FASEB J, October 1, 1998; 12(13): 1409 - 1417. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
